Home
Resources
Diseases
COVID-19
Hepatitis B
Human papillomavirus (HPV)
Malaria
Measles
Mpox
Pneumococcal disease
RSV (Respiratory syncytial virus)
Compendium
Hexavalent vaccines
HPV vaccines
Malaria vaccines
PCV vaccines
RSV vaccines
Training
Vaccine Portfolio Optimization and Prioritization (VPOP)
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Selected
COVID-19
Type of publications
Guidelines (1)
NITAG documentation (359)
Reports (1)
SAGE documentation (34)
Scientific publications (4)
Systematic reviews (SYSVAC) (1190)
Regions
Africa (62)
Americas (192)
Eastern Mediterranean (12)
Europe (160)
Global (1)
South-East Asia (11)
Western Pacific (39)
Diseases
COVID-19 (1589)
Chikungunya (13)
Cholera (35)
Cytomegalovirus (1)
Dengue (43)
Diphtheria (90)
Ebola (19)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (71)
Hepatitis A (69)
Hepatitis B (171)
Hepatitis C (5)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (77)
HIV / AIDS (10)
Human papillomavirus (HPV) (537)
Influenza (629)
Japanese encephalitis (34)
Lyme disease, Borreliosis (2)
Malaria (33)
Measles (144)
Meningococcal disease (155)
Moraxella catarrhalis (1)
Mpox (58)
Mumps (50)
Pertussis (120)
Pneumococcal disease (305)
Poliomyelitis (94)
Q fever (1)
Rabies (33)
Rotavirus (121)
RSV (Respiratory syncytial virus) (69)
Rubella (69)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (71)
Tick-borne encephalitis (14)
Tuberculosis (83)
Typhoid (32)
Varicella (77)
Yellow fever (44)
Zika (1)
Show more
Methodological quality (AMSTAR 2)
High (13)
Moderate (9)
Low (130)
Critically low (729)
Not applicable (309)
1589 results found
2021
∙
Cavanna, L. Citterio, C. Toscani, I.
Covid‐19 vaccines in cancer patients. Seropositivity and safety. systematic review and meta‐analysis
2021
∙
Sathian, B. Asim, M. Banerjee, I. Roy, B. Pizarro, A. B. Mancha, M. A. Van Teijlingen, E. R. Kord-Varkaneh, H. Mekkodathil, A. A. Subramanya, S. H. Do Nascimento, I. J. B. Antony, N. Menezes, R. G. Simkhada, P. Al Hamad, H.
Development and implementation of a potential coronavirus disease 2019 (COVID-19) vaccine: A systematic review and meta-analysis of vaccine clinical trials
2021
∙
Li, Y. P. Cai, J. W. Liao, L. J. Ding, H. Cao, X. J. Zhu, G. D. Guo, X. G.
Effect of BCG vaccination against SARS-CoV-2 infection
2021
∙
Liu, Q. Qin, C. Liu, M. Liu, J.
Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis
2021
∙
Harder, T. Külper-Schiek, W. Reda, S. Treskova-Schwarzbach, M. Koch, J. Vygen-Bonnet, S. Wichmann, O.
Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection with the Delta (B.1.617.2) variant: second interim results of a living systematic review and meta-analysis, 1 January to 25 August 2021
2021
∙
Kuznetsova, L. Cortassa, G. Trilla, A.
Effectiveness of mandatory and incentive-based routine childhood immunization programs in europe: A systematic review of the literature
2021
∙
Cheng, C. J. Lu, C. Y. Chang, Y. H. Sun, Y. Chu, H. J. Lee, C. Y. Liu, C. H. Lin, C. H. Lu, C. J. Li, C. Y.
Effectiveness of the who-authorized covid-19 vaccines: A rapid review of global reports till 30 june 2021
2021
∙
Harder, T. Koch, J. Vygen-Bonnet, S. Külper-Schiek, W. Pilic, A. Reda, S. Scholz, S. Wichmann, O.
Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021
2021
∙
Cheng, H. Peng, Z. Luo, W. Si, S. Mo, M. Zhou, H. Xin, X. Liu, H. Yu, Y.
Efficacy and safety of covid-19 vaccines in phase iii trials: A meta-analysis
2021
∙
Xing, K. Tu, X. Y. Liu, M. Liang, Z. W. Chen, J. N. Li, J. J. Jiang, L. G. Xing, F. Q. Jiang, Y.
Efficacy and safety of COVID-19 vaccines: a systematic review
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register